06.06.2013 Views

Donepezil, rivastigmine, galantamine and memantine for ...

Donepezil, rivastigmine, galantamine and memantine for ...

Donepezil, rivastigmine, galantamine and memantine for ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TABLE 1 Estimated prevalence of AD by age in Engl<strong>and</strong> <strong>and</strong> Wales<br />

Age group (years) Population of Engl<strong>and</strong> <strong>and</strong> Wales<br />

Estimated prevalence <strong>for</strong> Engl<strong>and</strong> <strong>and</strong><br />

Wales<br />

Table 1 uses the prevalence rates <strong>for</strong> AD from the<br />

pooled estimates in the study by Lobo <strong>and</strong><br />

colleagues 9 to provide an estimate of the prevalence<br />

of AD <strong>for</strong> the population of Engl<strong>and</strong> <strong>and</strong> Wales<br />

(based on mid-2002 population estimates). 20 This<br />

shows that there are approximately 290,000<br />

people in Engl<strong>and</strong> <strong>and</strong> Wales with AD. Assuming<br />

that 50–64% of people with AD have the mild to<br />

moderate <strong>for</strong>m of the disease we would expect to<br />

find between 145,000 <strong>and</strong> 185,600 cases of mild to<br />

moderate disease.<br />

Estimated prevalence <strong>for</strong> primary care<br />

trust<br />

Table 2 uses the same prevalence rates <strong>for</strong> AD as<br />

above to provide an estimate of the prevalence of<br />

AD <strong>for</strong> an average population of a primary care<br />

trust (PCT). A PCT with a population of 200,000<br />

might expect to have approximately 30,000 people<br />

over the age of 65 years <strong>and</strong> approximately 1100<br />

cases of AD. It can also be seen in Table 2 that,<br />

assuming that 50–64% of people with AD have the<br />

Health Technology Assessment 2006; Vol. 10: No. 1<br />

Males Females Prevalence of AD Estimated prevalence<br />

(rate/100 people) of AD<br />

© Queen’s Printer <strong>and</strong> Controller of HMSO 2006. All rights reserved.<br />

Male Female Males Females<br />

65–69 1,116,000 1,199,000 0.6 0.7 6,696 8,393<br />

70–74 950,000 1,126,000 1.5 2.3 14,250 25,898<br />

75–79 731,000 999,000 1.8 4.3 13,158 42,957<br />

80–84 470,000 786,000 6.3 8.4 29,610 66,024<br />

85–89 204,000 458,000 8.8 14.2 17,952 65,036<br />

Total 65+ 81,666 208,308<br />

Based on population data from mid-2002 estimates.<br />

TABLE 2 Estimated prevalence of AD by age <strong>for</strong> a st<strong>and</strong>ard PCT<br />

Age group (years) St<strong>and</strong>ard PCT (200,000 people)<br />

Population Prevalence of AD Estimated Estimated prevalence<br />

(rate/100 people) prevalence of AD of mild to moderate AD<br />

Male Female<br />

65–69 8822 0.6 0.7 58 29–37<br />

70–74 7911 1.5 2.3 153 76–98<br />

75–79 6593 1.8 4.3 213 106–136<br />

80–84 4786 6.3 8.4 364 182–233<br />

85–89 1823 8.8 14.2 316 158–202<br />

Total 65+ 1104 551–706<br />

mild to moderate <strong>for</strong>m of the disease, a PCT<br />

might expect to have between 551 <strong>and</strong> 706 cases<br />

of mild to moderate disease.<br />

Incidence<br />

The 1-year incidence of all-cause dementia<br />

increases from 0.01 per 1000 population at<br />

65 years to 80 per 1000 at age 85 years. 3 The<br />

incidence of AD appears to have been stable over<br />

the past two decades, although demographic<br />

changes (e.g. ageing population) may result in an<br />

increase in prevalence in the future. 16 Incidence<br />

rates <strong>for</strong> AD in those aged over 65 years from<br />

recent studies range from 4.9 per 1000 personyears<br />

21 in a UK study; 6.55 [95% confidence<br />

interval (CI) 4.92 to 8.17] per 1000 person-years<br />

in an Italian study; 22 <strong>and</strong> 14.26 (95% CI: 12.2 to<br />

16.7) 23 in a US study.<br />

Age-related incidence<br />

A recent pooled estimate from eight European<br />

population-based studies of persons aged<br />

≥ 65 years demonstrated rising incidence rates<br />

with increasing age. 24 The age-specific incidence<br />

5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!